Literature DB >> 8909136

Strategies for targeted gene therapy.

J D Harris1, N R Lemoine.   

Abstract

Genetic intervention for the therapy of human disease has long been a dream for scientists and clinicians alike, and the first steps towards reality have already been taken in clinical trials involving over 1000 patients around the world. The technology used in these initial experiments has limited potential for therapeutic effect and it is now appreciated that improvements in targeting gene delivery and gene expression are both required before real clinical benefit is achieved. The enormous advances made in the fields of molecular genetics and molecular biology of the last few years have set the scene for their translation into novel approaches to gene transfer and control, for gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909136     DOI: 10.1016/0168-9525(96)40031-2

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  4 in total

1.  A new peptide vector for efficient delivery of oligonucleotides into mammalian cells.

Authors:  M C Morris; P Vidal; L Chaloin; F Heitz; G Divita
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 2.  Genetic targeting of the renin-angiotensin system for long-term control of hypertension.

Authors:  Beverly L Metcalfe; Mohan Raizada; Michael J Katovich
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

3.  Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.

Authors:  Faye A Rogers; Muthiah Manoharan; Peter Rabinovitch; David C Ward; Peter M Glazer
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

4.  Ultrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entry.

Authors:  Shuaidong Huo; Shubin Jin; Xiaowei Ma; Xiangdong Xue; Keni Yang; Anil Kumar; Paul C Wang; Jinchao Zhang; Zhongbo Hu; Xing-Jie Liang
Journal:  ACS Nano       Date:  2014-05-22       Impact factor: 15.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.